Hiroaki Watabe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hiroaki Watabe has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Daigo Hiraya
Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
7 shared publications - Tomoya Hoshi
Department of Cardiology, Institute of Medicine University of Tsukuba Tsukuba Japan
7 shared publications Daigo Hiraya
Department of Cardiology, Faculty of Medicine, University of Tsukuba, Japan
5 shared publicationsTaikan Terauchi
Department of Cardiology, Faculty of Medicine, University of Tsukuba, Japan
5 shared publications- Tomoko Ishizu
Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
5 shared publications Tomoya Hoshi
Department of Cardiology, Faculty of Medicine, University of Tsukuba, Japan
5 shared publications
Latest Publications
- Open Access
- 7 May 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 457, 134552
Association between coronary high-intensity plaque and pericoronary adipose tissue attenuation and plaque morphology
- 7 May 2026
- Published by Elsevier in International Journal of Cardiology
- Vol. 457, 134552
Open AccessAssociation between coronary high-intensity plaque and pericoronary adipose tissue attenuation and plaque morphology
- Open Access
- 3 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (5) , e045599
Prognostic Value of Right Ventricular Free Wall Longitudinal Strain in Transcatheter Aortic Valve Implantation Outcomes
Background: Previously proposed staging classification based on cardiac damage highlighted that right ventricular (RV) damage reflects the most advanced stage in patients with severe aortic stenosis. This study aimed to investigate the association between RV damage detected by RV free wall longitudinal strain (RVFWLS) and outcomes in patients with severe aortic stenosis who underwent transcatheter aortic valve implantation (TAVI). Methods: A total of 768 patients with severe aortic stenosis who underwent TAVI and echocardiographic images for RV functional assessment were included from a retrospective multicenter TAVI registry. The primary outcome was a composite of all‐cause death and hospitalization due to cardiovascular events. Results: During a median follow‐up of 21 (12–30) months, 213 patients (28%) experienced the primary end points. In the multivariable Cox proportional hazards model, a higher absolute RVFWLS value was independently associated with better outcomes (adjusted hazard ratio [HR], 0.88 [95% CI, 0.84–0.91]). RVFWLS demonstrated incremental values superior to those of conventional RV parameters. Adding RVFWLS <17% as an RV damage (Stage 4) criterion in staging classification identified 272 (35%) patients in Stage 4. Patients with RVFWLS‐incorporated Stage 4 had lower event‐free survival than did those in the other stages (adjusted HR, 1.55 [95% CI, 1.35–1.77]). Conclusion: In patients with severe aortic stenosis who underwent TAVI, RVFWLS was independently associated with outcomes and provided superior prognostic value than other conventional RV echocardiographic parameters. Incorporating RVFWLS in a staging classification for RV damage showed incremental value for predicting survival after TAVI over the original staging classification.
- 3 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (5) , e045599
Open AccessPrognostic Value of Right Ventricular Free Wall Longitudinal Strain in Transcatheter Aortic Valve Implantation Outcomes
Background: Previously proposed staging classification based on cardiac damage highlighted that right ventricular (RV) damage reflects the most advanced stage in patients with severe aortic stenosis. This study aimed to investigate the association between RV damage detected by RV free wall longitudinal strain (RVFWLS) and outcomes in patients with severe aortic stenosis who underwent transcatheter aortic valve implantation (TAVI). Methods: A total of 768 patients with severe aortic stenosis who underwent TAVI and echocardiographic images for RV functional assessment were included from a retrospective multicenter TAVI registry. The primary outcome was a composite of all‐cause death and hospitalization due to cardiovascular events. Results: During a median follow‐up of 21 (12–30) months, 213 patients (28%) experienced the primary end points. In the multivariable Cox proportional hazards model, a higher absolute RVFWLS value was independently associated with better outcomes (adjusted hazard ratio [HR], 0.88 [95% CI, 0.84–0.91]). RVFWLS demonstrated incremental values superior to those of conventional RV parameters. Adding RVFWLS <17% as an RV damage (Stage 4) criterion in staging classification identified 272 (35%) patients in Stage 4. Patients with RVFWLS‐incorporated Stage 4 had lower event‐free survival than did those in the other stages (adjusted HR, 1.55 [95% CI, 1.35–1.77]). Conclusion: In patients with severe aortic stenosis who underwent TAVI, RVFWLS was independently associated with outcomes and provided superior prognostic value than other conventional RV echocardiographic parameters. Incorporating RVFWLS in a staging classification for RV damage showed incremental value for predicting survival after TAVI over the original staging classification.
- Open Access
- 4 February 2026
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 20 (3) , 211-218
Coronary plaque volume quantification using coronary computed tomography angiography is associated with periprocedural myocardial injury in patients with chronic coronary syndrome
- 4 February 2026
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 20 (3) , 211-218
Open AccessCoronary plaque volume quantification using coronary computed tomography angiography is associated with periprocedural myocardial injury in patients with chronic coronary syndrome
- 19 March 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (10) , 1338-1341
Alcohol Septal Ablation Using the Balloon Screen Technique for Severely Angulated Septal Branches
- 19 March 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (10) , 1338-1341
Alcohol Septal Ablation Using the Balloon Screen Technique for Severely Angulated Septal Branches
- 4 December 2024
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 11 (2) , 454-457
Delayed Endothelialization of Left Atrial Appendage Closure Device
- 4 December 2024
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 11 (2) , 454-457
Delayed Endothelialization of Left Atrial Appendage Closure Device
- Open Access
- 27 November 2024
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (4) , 102710
1-Stage Treatment of Dual Stenosis by Simultaneous Alcohol Septal Ablation and Transcatheter Aortic Valve Implantation
- 27 November 2024
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (4) , 102710
Open Access1-Stage Treatment of Dual Stenosis by Simultaneous Alcohol Septal Ablation and Transcatheter Aortic Valve Implantation
- Open Access
- 2 September 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (1) , 169
Direct visualization of cardiac and pulmonary artery tumours and intra-cardiac biopsy with non-obstructive general angioscopy
Takumi Yaguchi, Hiroaki Watabe, Daigo Hiraya, Tomoya Hoshi, Tomoko Ishizu; Direct visualization of cardiac and pulmonary artery tumors and intracardiac bio
- 2 September 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (1) , 169
Open AccessDirect visualization of cardiac and pulmonary artery tumours and intra-cardiac biopsy with non-obstructive general angioscopy
Takumi Yaguchi, Hiroaki Watabe, Daigo Hiraya, Tomoya Hoshi, Tomoko Ishizu; Direct visualization of cardiac and pulmonary artery tumors and intracardiac bio
- 23 October 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (20) , 2569-2571
Nonobstructive General Angioscopy-Guided Intraventricular Tumor Biopsy
- 23 October 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (20) , 2569-2571
Nonobstructive General Angioscopy-Guided Intraventricular Tumor Biopsy
- 19 September 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (42) , 4490
Coronary manifestations of immunoglobulin G4-related disease
- 19 September 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (42) , 4490
Coronary manifestations of immunoglobulin G4-related disease
- Open Access
- 3 July 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 7 (7) , ytad304
Emergency transcatheter aortic valve implantation with a self-expandable valve under extracorporeal membrane oxygenation for cardiogenic shock due to bicuspid aortic stenosis: a case report
Background: Transcatheter aortic valve implantation (TAVI) is an established treatment for patients with severe aortic stenosis (AS). However, the effectiveness of TAVI for patients with cardiogenic shock due to severe bicuspid AS, who require mechanical circulatory support, needs further investigation. Case summary: A 64-year-old male patient was admitted to the hospital with congestive heart failure secondary to severe AS and severe left ventricular dysfunction. After admission, he developed cardiogenic shock, further worsening his condition. The patient was placed on veno-arterial extracorporeal membrane oxygenation support and an intra-aortic balloon pump and transferred to our hospital. Cardiac computed tomography revealed a severely calcified type 1 bicuspid valve. The patient was deemed inoperable by our heart team. Therefore, an emergency transfemoral TAVI with a self-expandable valve was performed on Day 2. It significantly improved his haemodynamic stability. The patient was finally discharged on Day 29 without any neurological sequelae. Discussion: Cardiogenic shock due to severe AS has poor prognosis. However, this case report demonstrates that TAVI could be the optimal treatment for haemodynamically unstable patients with severe AS who require mechanical circulatory support.
- 3 July 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 7 (7) , ytad304
Open AccessEmergency transcatheter aortic valve implantation with a self-expandable valve under extracorporeal membrane oxygenation for cardiogenic shock due to bicuspid aortic stenosis: a case report
Background: Transcatheter aortic valve implantation (TAVI) is an established treatment for patients with severe aortic stenosis (AS). However, the effectiveness of TAVI for patients with cardiogenic shock due to severe bicuspid AS, who require mechanical circulatory support, needs further investigation. Case summary: A 64-year-old male patient was admitted to the hospital with congestive heart failure secondary to severe AS and severe left ventricular dysfunction. After admission, he developed cardiogenic shock, further worsening his condition. The patient was placed on veno-arterial extracorporeal membrane oxygenation support and an intra-aortic balloon pump and transferred to our hospital. Cardiac computed tomography revealed a severely calcified type 1 bicuspid valve. The patient was deemed inoperable by our heart team. Therefore, an emergency transfemoral TAVI with a self-expandable valve was performed on Day 2. It significantly improved his haemodynamic stability. The patient was finally discharged on Day 29 without any neurological sequelae. Discussion: Cardiogenic shock due to severe AS has poor prognosis. However, this case report demonstrates that TAVI could be the optimal treatment for haemodynamically unstable patients with severe AS who require mechanical circulatory support.